Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
ADVM holding history
Adverum Biotechnologies, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ADVM overviewAll 13F holders of ADVMFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −21,730−100.0% | Sold out | Holders |
| Q3 2025 | 21,730 | $98.4K | <0.1% | −8,949−29.2% | Reduced | Holders |
| Q2 2025 | 30,679 | $66.0K | <0.1% | +30,679 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −16,265−100.0% | Sold out | Holders |
| Q2 2024 | 16,265 | $111.6K | <0.1% | −25,354−60.9% | Reduced | Holders |
| Q1 2024 | 41,619 | $588.5K | <0.1% | +41,547+57,946.0% | AddedConverted for a 1-for-10 split | Holders |
| Q4 2023 | 717 | $540 | <0.1% | −24,250−97.1% | Reduced | Holders |
| Q3 2023 | 24,967 | $37.5K | <0.1% | +24,967 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −67,564−100.0% | Sold out | Holders |
| Q3 2022 | 67,564 | $64.0K | <0.1% | −16,322−19.5% | Reduced | Holders |
| Q2 2022 | 83,886 | $101.0K | <0.1% | +83,886 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −23,662−100.0% | Sold out | Holders |
| Q3 2021 | 23,662 | $51.0K | <0.1% | +23,662 | New | Holders |